Advertisement
 

Watson Profit Rises on Strong Generic Sales

IN BRIEF / EARNINGS

November 06, 2003|From Reuters

Watson Pharmaceuticals Inc. said its third-quarter profit rose on strong sales of generic drugs and the company's new patch for overactive bladders.

The Corona company reported earnings of $51.5 million, or 47 cents a share, compared with $40.7 million, or 38 cents, a year earlier. Revenue rose 17% to $358.8 million.

Watson's shares rose $3.88, or 10%, to $42.32 on the NYSE.

Advertisement
Los Angeles Times Articles
|
|
|